EXAS vs TTI · rev $2.76B vs P/E 170, $1.50B cap
EXACT Sciences Corporation (EXAS) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
TTI does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the EXAS and TTI stock pages for the full models.
Not investment advice.